Join
Live feed
·
PRReleasevia Quantisnow
Emergent BioSolutions Inc. logo
SAB Biotherapeutics Inc. logo

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

ByQuantisnow·Wall Street's wire, on your screen.
EBS· Emergent BioSolutions Inc.SABS· SAB Biotherapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBS (Emergent BioSolutions Inc.), SABS (SAB Biotherapeutics Inc.) and more on Quantisnow.